GMABGenmab A/S

$33.54

$23.8252 weeks$35.34

Is the price fair?

Genmab A/S has no trailing P/E on file, so the price is measured against sales instead: 0.04× revenue.

0.04

Price / sales · no trailing P/E on file: measured against sales instead

Details›

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Ranks #2 of 143 by Smart Score